Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 425

1.

Eugen Bleuler's schizophrenia-a modern perspective.

Maatz A, Hoff P, Angst J.

Dialogues Clin Neurosci. 2015 Mar;17(1):43-9.

2.

The Kraepelinian tradition.

Hoff P.

Dialogues Clin Neurosci. 2015 Mar;17(1):31-41.

3.

The impact of complete chemotherapy stop on the overall survival of patients with advanced colorectal cancer in first-line setting: A meta-analysis of randomized trials.

Pereira AA, Rego JF, Munhoz RR, Hoff PM, Sasse AD, Riechelmann RP.

Acta Oncol. 2015 May 18:1-10. [Epub ahead of print]

PMID:
25984931
4.

Effects of ECT in treatment of depression: study protocol for a prospective neuroradiological study of acute and longitudinal effects on brain structure and function.

Oltedal L, Kessler U, Ersland L, Grüner R, Andreassen OA, Haavik J, Hoff PI, Hammar Å, Dale AM, Hugdahl K, Oedegaard KJ.

BMC Psychiatry. 2015 May 1;15:94. doi: 10.1186/s12888-015-0477-y.

5.

Effect of flecainide on the extension and localization of complex fractionated electrogram during atrial fibrillation.

De Bortoli A, Shi LB, Wang YC, Hoff PI, Solheim E, Ohm OJ, Chen J.

Scand Cardiovasc J. 2015 Jun;49(3):168-75. doi: 10.3109/14017431.2015.1036920. Epub 2015 Apr 27.

PMID:
25915187
6.

Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer.

Petry V, Gagliato DM, Leal AI, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS.

Braz J Med Biol Res. 2015 May;48(5):479-85. doi: 10.1590/1414-431X20144354. Epub 2015 Mar 6.

7.

Equivariant minimax dominators of the MLE in the array normal model.

Gerard D, Hoff P.

J Multivar Anal. 2015 May 1;137:32-49.

PMID:
25745274
8.

Phase I trials of antitumour agents: fundamental concepts.

Toloi Dde A, Jardim DL, Hoff PM, Riechelmann RS.

Ecancermedicalscience. 2015 Jan 19;9:501. doi: 10.3332/ecancer.2015.501. eCollection 2015. Review.

9.

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.

Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S.

Br J Cancer. 2015 Mar 17;112(6):1088-97. doi: 10.1038/bjc.2015.61.

PMID:
25688736
10.

Marginally specified priors for non-parametric Bayesian estimation.

Kessler DC, Hoff PD, Dunson DB.

J R Stat Soc Series B Stat Methodol. 2015 Jan 1;77(1):35-58.

PMID:
25663813
11.

Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.

Spies CM, Hoff P, Mazuch J, Gaber T, Maier B, Strehl C, Hahne M, Jakstadt M, Huscher D, Burmester GR, Detert J, Kramer A, Buttgereit F.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.

PMID:
25535886
12.

Association between KRAS mutation and lung metastasis in advanced colorectal cancer.

Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ, Hoff PM, Vauthey JN, Vilar E, Maru D, Kopetz S.

Br J Cancer. 2015 Feb 3;112(3):424-8. doi: 10.1038/bjc.2014.619. Epub 2014 Dec 23.

PMID:
25535726
13.

SEPARABLE FACTOR ANALYSIS WITH APPLICATIONS TO MORTALITY DATA.

Fosdick BK, Hoff PD.

Ann Appl Stat. 2014;8(1):120-147.

14.

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.

Ruff P, Ferry DR, Lakomỳ R, Prausová J, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, Ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Van Cutsem E.

Eur J Cancer. 2015 Jan;51(1):18-26. doi: 10.1016/j.ejca.2014.10.019. Epub 2014 Nov 14.

15.

The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.

Crosara Teixeira M, Marques DF, Ferrari AC, Alves MF, Alex AK, Sabbaga J, Hoff PM, Riechelmann RP.

Clin Colorectal Cancer. 2015 Mar;14(1):52-7. doi: 10.1016/j.clcc.2014.09.010. Epub 2014 Oct 18.

PMID:
25442812
16.

Body mass index predicts success in patients undergoing transoral robotic surgery for obstructive sleep apnea.

Hoff PT, Glazer TA, Spector ME.

ORL J Otorhinolaryngol Relat Spec. 2014;76(5):266-72. doi: 10.1159/000368415. Epub 2014 Nov 20.

PMID:
25413253
17.

Cardiac safety of (neo)adjuvant trastuzumab in the community setting: a single-center experience.

da Fonseca LG, de Melo Gagliato D, Takahashi TK, Mak MP, Barroso-Sousa R, Testa L, Helena VP, de Paula Costa R, Hoff PM, Mano MS.

Breast Care (Basel). 2014 Apr;9(4):255-60. doi: 10.1159/000365950.

19.

Transoral robotic surgery in benign diseases including obstructive sleep apnea: Safety and feasibility.

Hoff PT, D'Agostino MA, Thaler ER.

Laryngoscope. 2015 May;125(5):1249-53. doi: 10.1002/lary.25026. Epub 2014 Nov 12.

PMID:
25388791
20.

Primary prevention of colorectal cancer: myth or reality?

Crosara Teixeira M, Braghiroli MI, Sabbaga J, Hoff PM.

World J Gastroenterol. 2014 Nov 7;20(41):15060-9. doi: 10.3748/wjg.v20.i41.15060.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk